Silver Book Fact

The national economic burden of Parkinson’s disease in 20130 exceeded $14.4 billion–approximately $22,800 per patient.

Kowal, Stacey L, Timothy Mm Dall, Ritashree Chakrabarti, Michael V Storm, and Anjali Jain. The Current and Projected Economic Burden of Parkinson’s Disease in the United States. Movement Disorders. 2013; http://onlinelibrary.wiley.com/doi/10.1002/mds.25292/abstract

Reference

Title
The Current and Projected Economic Burden of Parkinson’s Disease in the United States
Publication
Movement Disorders
Publication Date
2013
Authors
Kowal, Stacey L, Timothy Mm Dall, Ritashree Chakrabarti, Michael V Storm, and Anjali Jain
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 1 in 6 women and 1 in 10 men who live to be at least 55 years old will develop Alzheimer’s disease in their lifetime.  
  • On average, Medicare spends about 3 times more per beneficiary diagnosed with Alzheimer’s or other dementias, compared to someone who does not have dementia ($13,207 compared to $4,454).  
  • Drug therapy for Parkinson’s disease costs more than $6 billion a year. Costs such as rehabilitation and home care can run as high as $150,000 per patient, per year.  
  • About 47% of nursing home residents have a diagnosis of Alzheimer’s or another dementia in their medical record.””  
  • Between 2005 and 2010, total health care spending for people with dementia was more than $287,000 per person, nearly 60
    Between 2005 and 2010, total health care spending for people with dementia was more than $287,000 per person, nearly 60% percent greater than costs associated with death from other diseases, such as cancer…